Mustang Bio (STU:2W60) Ending Cash Position: €13.15 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:2W60 Mustang Bio Inc STU:2W60
30 GF Score
Price €244.50
! 2 Warning Signs
View Full Analysis

What is Mustang Bio Ending Cash Position?

Mustang Bio STU:2W60 30 Ending Cash Position is €13.15 Mil as of Jun. 2026. GuruFocus rates STU:2W60 with a GF Score™ of 30/100. The stock has 2 warning signs investors should review.

Mustang Bio's Ending Cash Position for the quarter that ended in Jun. 2026 was €13.15 Mil.

Mustang Bio's quarterly Ending Cash Position declined from Dec. 2025 (€14.75 Mil) to Mar. 2026 (€14.06 Mil) and declined from Mar. 2026 (€14.06 Mil) to Jun. 2026 (€13.15 Mil).

Mustang Bio's annual Ending Cash Position increased from Dec. 2023 (€6.40 Mil) to Dec. 2024 (€6.53 Mil) and increased from Dec. 2024 (€6.53 Mil) to Dec. 2025 (€14.75 Mil).

Mustang Bio Ending Cash Position Related Terms

Mustang Bio Ending Cash Position Historical Data

* Premium members only.

The historical data trend for Mustang Bio's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mustang Bio Ending Cash Position Chart

Mustang Bio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 97.90 72.36 6.40 6.53 14.75

Mustang Bio Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.97 16.17 14.75 14.06 13.15
STU:2W60
30GF Score
Mustang Bio Inc STU:2W60
Ending Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Mustang Bio Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Mustang Bio's Ending Cash Position for the fiscal year that ended in Dec. 2025 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=5.84+8.905
=14.75

Mustang Bio's Ending Cash Position for the quarter that ended in Jun. 2026 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=14.111+-0.961
=13.15

Frequently Asked Questions Learn more about Ending Cash Position →
What does a Ending Cash Position of €13.15 Mil mean?
Mustang Bio (STU:2W60) has a Ending Cash Position of €13.15 Mil as of Jun. 2026. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Mustang Bio and its competitors.
Is Mustang Bio's Ending Cash Position too high?
Mustang Bio's current Ending Cash Position is €13.15 Mil. Overall, Mustang Bio has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Mustang Bio's Ending Cash Position compare to TCRT and REVB?
Mustang Bio's Ending Cash Position of €13.15 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Ending Cash Position for a Biotechnology company?
A good Ending Cash Position depends on the Biotechnology industry context. However, Ending Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Ending Cash Position mean?
A high Ending Cash Position can signal that a stock is expensive relative to its fundamentals. Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. View historical data on Mustang Bio and its competitors. Mustang Bio's current Ending Cash Position is €13.15 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mustang Bio stock overvalued right now?
Mustang Bio (STU:2W60) has a current Ending Cash Position of €13.15 Mil. The current Ending Cash Position is €13.15 Mil. Mustang Bio's overall GF Score™ is 30/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Ending Cash Position calculated?
Ending Cash Position is calculated from a company's financial statements. For Mustang Bio (STU:2W60), the current Ending Cash Position is €13.15 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Mustang Bio Business Description

Other Exchanges MBIO:USA
Address 95 Sawyer Road, Suite 110, Waltham, MA, USA, 02453
Mustang Bio Inc is a clinical-stage biopharmaceutical company focused on translating today's medical breakthroughs into potential cures for difficult-to-treat cancers. It acquires rights to these technologies by licensing or otherwise acquiring an ownership interest in the technologies, funding their research and development, and eventually either out-licensing or bringing the technologies to market. Its pipeline is currently focused on the core areas of gene therapies for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (CAR T) therapies for hematologic malignancies, and CAR T therapies for solid tumors.
30GF Score

Get the complete analysis for STU:2W60

Ending Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€244.50
Price